TMO
Thermo Fisher Scientific Inc.
Stock
$675.05−4.56 (−0.67%)Close Sep 30, 2026
| Long-term debt (Q2 2026) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $39.2B | +18.7% | 13.4% | 12.1% |
| Long-term debt (Q2 2026) | $39.2B |
|---|---|
| YoY | +18.7% |
| 5-year CAGR | 13.4% |
| 10-year CAGR | 12.1% |
Long-term debt
| Period | Long-term debt | YoY |
|---|---|---|
| 2025 | $35.9B | +23.4% |
| 2024 | $29.1B | −7.2% |
| 2023 | $31.3B | +8.3% |
| 2022 | $28.9B | −10.6% |
| 2021 | $32.3B | +69.2% |
| 2020 | $19.1B | +11.9% |
| 2019 | $17.1B | −3.6% |
| 2018 | $17.7B | −6.1% |
| 2017 | $18.9B | +22.8% |
| 2016 | $15.4B | +34.6% |
| 2015 | $11.4B | −7.5% |
| 2014 | $12.4B | +30.0% |
| 2013 | $9.5B | +35.1% |
| 2012 | $7.0B | +22.2% |
| 2011 | $5.8B | +183.3% |
| 2010 | $2.0B | −1.6% |
| 2009 | $2.1B | +3.0% |
| 2008 | $2.0B | — |